USPTO Examiner DUKERT BRIAN AINSLEY - Art Unit 3774

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19178260Mandibular reconstruction systems and methodsApril 2025July 2025Allow300NoNo
18948149SYSTEMS AND METHODS OF THUMB CAROPMETACARPAL JOINTS IMPLANTSNovember 2024June 2025Allow711YesNo
18826141Stemless Semi-Constrained Implantable Joint Replacement DeviceSeptember 2024October 2025Abandon1311NoNo
18734857DEMINERALIZED BONE FIBER COMPOSITION FOR ROTATOR CUFF AND ACL REPAIRJune 2024February 2026Allow2110NoNo
18735159PROSTHETIC FEMORAL HEAD AND METHOD OF MAKING THE SAMEJune 2024April 2025Allow1010NoNo
18587117STENT STRUCTURES FOR USE WITH VALVE REPLACEMENTSFebruary 2024January 2025Allow1120YesNo
18519992ACETABULAR CUP AND HIP JOINT PROSTHESIS ASSEMBLYNovember 2023May 2025Allow1730NoNo
18206224Implantable Joint Having Heating SystemJune 2023April 2024Allow1020YesNo
18133654Intra-Operative Gap DetectionApril 2023February 2026Allow3400NoNo
18127986Self-Powered ProsthesisMarch 2023February 2026Allow3400NoNo
18183895DEMINERALIZED BONE FIBER COMPOSITION FOR ROTATOR CUFF AND ACL REPAIRMarch 2023April 2024Allow1310NoNo
18042941SYSTEMS AND METHODS FOR AN ANKLE PROSTHESISFebruary 2023February 2026Allow3500NoNo
18171258IMPLANTABLE FRAME AND FRAME RETAINING MECHANISMFebruary 2023January 2026Allow3510NoNo
18098452SOFT GLENOID AWNING AND RELATED REPAIR PROCEDURESJanuary 2023February 2026Allow3711YesNo
18154573STENT STRUCTURES FOR USE WITH VALVE REPLACEMENTSJanuary 2023October 2023Allow900NoNo
18096511EXPANSION AND LOCKING ASSEMBLIES WITH INTERTWINED WIRESJanuary 2023March 2026Allow3810NoNo
18088436STOMACH LINING PATCH WITH CENTRAL FIXATIONDecember 2022April 2025Abandon2710NoNo
18076143REINFORCEMENT INSERT FOR TISSUE GRAFTDecember 2022April 2025Abandon2810NoNo
18058214METHODS AND DEVICES FOR LESS INVASIVE GLENOID REPLACEMENTNovember 2022January 2025Abandon2621NoYes
18058165METHODS AND DEVICES FOR LESS INVASIVE GLENOID REPLACEMENTNovember 2022December 2023Allow1321NoNo
17981395EXPANDABLE SHEATH FOR INTRODUCING AN ENDOVASCULAR DELIVERY DEVICE INTO A BODYNovember 2022March 2026Allow4010NoNo
17921183SHOULDER PROSTHESISOctober 2022June 2024Allow2020YesNo
18049579PERICARDIAL SEALING MEMBER FOR PROSTHETIC HEART VALVEOctober 2022August 2023Allow1020NoNo
17968506MULTIPLE INFLATION ENDOVASCULAR MEDICAL DEVICEOctober 2022June 2025Allow3211YesNo
17965693BIODEGRADABLE STENTOctober 2022October 2025Allow3611NoNo
17915384Artificial Ankle Joint Bearing ElementSeptember 2022March 2026Abandon4210NoNo
17915432ARTIFICIAL JOINT STEM AND METHOD FOR MANUFACTURING ARTIFICIAL JOINT STEMSeptember 2022February 2026Allow4010NoNo
17892459IMPLANTABLE COMPOSITIONS HAVING FIBERS AND METHODS OF MAKING AND USING THEMAugust 2022March 2026Allow4311NoNo
17904710EXTRACORPOREALLY LENGTH-ADJUSTABLE IMPLANT SYSTEM, AND LENGTH-ADJUSTABLE IMPLANT COMPONENTAugust 2022February 2026Allow4210NoNo
17891390Multi-Size Acetabular ImpactorAugust 2022April 2024Allow2000NoNo
17886213STENT GRAFT MONITORING ASSEMBLY AND METHOD OF USE THEREOFAugust 2022October 2025Allow3800NoNo
17884005DESIGNING AND MANUFACTURING PROSTHETIC IMPLANTSAugust 2022July 2023Allow1120YesNo
17813790Stent Assembly For Use in Prosthetic Heart ValvesJuly 2022March 2025Allow3210NoNo
17867828CONSTRAINED ACETABULAR LINERJuly 2022January 2025Allow3000NoNo
17850520HUMERAL TRAYS WITH TUBEROSITY AUGMENTS SUFFICIENTLY DESIGNED TO IMPROVE JOINT MECHANICSJune 2022July 2025Allow3720NoNo
17846240Joint Replacement Augments and Associated InstrumentationJune 2022March 2025Allow3311YesNo
17838320HUMERAL HEAD IMPLANT SYSTEMJune 2022October 2022Allow410NoNo
17824535HIP IMPLANT WITH REDUCED WEARMay 2022March 2023Allow920NoNo
17751047Total Ankle Replacement ProsthesisMay 2022November 2024Allow3010NoNo
17740845TIBIAL TRAY WITH FIXATION FEATURESMay 2022May 2025Allow3620NoNo
17740813ACETABULAR PROSTHESIS WITH ADJUSTABLE ACETABULAR CUP CAGESMay 2022April 2024Allow2320NoNo
17661629MODULAR TOTAL KNEE ARTHROPLASTY SYSTEM AND METHODMay 2022August 2024Allow2700NoNo
17732862Bendable Titanium-Alloy Implants, And Related Systems And MethodsApril 2022October 2025Allow4240YesNo
17732830Fixation Device Having a Flexure PortionApril 2022July 2024Allow2700NoNo
17661061HIP ARTHROPLASTY IMPLANTSApril 2022July 2024Allow2600NoNo
17660950HIP ARTHROPLASTY IMPLANTSApril 2022December 2025Allow4410NoNo
17660047UNICOMPARTMENTAL ANKLE PROSTHESISApril 2022October 2023Allow1800NoNo
17719157ANGLED BASEPLATE FOR HUMERAL AND GLENOID ARTICULAR SURFACE IMPLANT SYSTEMS AND METHODSApril 2022February 2024Allow2210YesNo
17658299JOINT OSTEOTOMY SYSTEM AND METHODApril 2022December 2025Allow4411NoNo
17707909PROSTHETIC HEART VALVE DEVICES AND ASSOCIATED SYSTEMS AND METHODSMarch 2022August 2023Abandon1821NoNo
17707920PROSTHETIC HEART VALVE DEVICES AND ASSOCIATED SYSTEMS AND METHODSMarch 2022October 2022Allow710NoNo
17655611JOINT OSTEOTOMY SYSTEM AND METHODMarch 2022August 2022Allow510NoNo
17692809SYSTEM AND METHOD TO FUSE BONEMarch 2022October 2025Allow4320YesNo
17686823CERAMIC ACETABULAR SHELL LINERS WITH AUGMENTSMarch 2022December 2024Allow3410NoNo
17680277KNIT SPINAL IMPLANT RETENTION AND RELEASE SYSTEM AND METHODFebruary 2022May 2025Allow3930YesNo
17678401Leaflet Attachment To Prosthetic Heart ValveFebruary 2022March 2025Allow3631NoNo
17652004GLENOID IMPLANT HAVING MULTIPLE SECTIONS OF DIFFERING DIAMETERSFebruary 2022October 2023Abandon2020NoYes
17676490JOINT IMPLANT APPARATUS, SYSTEM, AND METHODFebruary 2022August 2025Allow4221YesNo
17650952ARTIFICIAL SPINAL PROSTHESIS AND METHODFebruary 2022January 2023Allow1220YesNo
17666926Mitral StentFebruary 2022April 2025Allow3830YesNo
17649088MULTIAXIAL MODULAR TIBIA STEMSJanuary 2022October 2025Allow4411NoNo
17575542SYSTEM AND METHOD TO FUSE BONEJanuary 2022December 2025Allow4710NoNo
17571971FEMORAL COMPONENT FOR A KNEE PROSTHESIS WITH IMPROVED ARTICULAR CHARACTERISTICSJanuary 2022October 2024Allow3310NoNo
17568105ADJUSTABLE SUTURE BUTTON CONSTRUCTJanuary 2022July 2025Allow4220NoNo
17597217Compact device designed to be positioned close to a joint and general system comprising such a compact deviceDecember 2021May 2023Allow1720NoNo
17558087CLOWARD-STYLE CERVICAL MESH CAGE WITH LATERAL STABILIZERSDecember 2021July 2025Allow4311NoNo
17551063ARTHROPLASTY SYSTEMS AND METHODSDecember 2021February 2025Abandon3810NoNo
17617752STENT WITH IMMEDIATELY REMOVEABLE COATINGDecember 2021January 2026Allow5020NoNo
17543416METHOD FOR IMPLANTING A HIP PROSTHESIS AND RELATED SYSTEMDecember 2021May 2025Allow4211NoNo
17536961MODULAR VARIABLE ANGLE BLADE AUGMENTNovember 2021September 2024Allow3420NoNo
17535767HIP JOINT DEVICE AND METHODNovember 2021January 2026Allow5031NoNo
17613995HIP JOINT IMPLANT WITH RESHAPEABLE FASTENING BRACKETSNovember 2021January 2025Allow3820YesNo
17532714Humeral Implant and MethodNovember 2021October 2025Allow4741YesYes
17455130OFF-CENTER LINER FOR ACETABULAR CUPNovember 2021August 2023Allow2110YesNo
17609176VALVED CONDUIT WITH EXPANDABLE FRAMENovember 2021January 2026Allow5121NoNo
17516069ELECTROSPUN PTFE COATED STENT AND METHOD OF USENovember 2021March 2026Allow5211NoNo
17512182EXPANDING INTERVERTEBRAL IMPLANTSOctober 2021October 2024Allow3510NoNo
17497711SHOULDER ARTHROPLASTY IMPLANT SYSTEMOctober 2021June 2025Allow4411NoNo
17450183GUIDES AND INSTRUMENTS FOR IMPROVING ACCURACY OF GLENOID IMPLANT PLACEMENTOctober 2021February 2025Allow4111NoNo
17496442ANKLE PROSTHESIS WITH SIMPLIFIED ADJUSTMENTOctober 2021February 2026Allow5230NoNo
17602197PROSTHESIS FOR ACETABULUM FRACTURESOctober 2021November 2024Allow3710NoNo
17494903PATIENT-SPECIFIC ARTIFICIAL TEMPOROMANDIBULAR JOINTOctober 2021November 2024Abandon3720NoNo
17494997PLATELET-ACTIVATED BIOADHESIVE STENT COATING AS AN ANTI-MIGRATION MECHANISMOctober 2021December 2024Allow3810YesNo
17494965CONVERTIBLE ORTHOPAEDIC IMPLANT SYSTEMS AND METHODSOctober 2021June 2025Allow4411NoNo
17492803Humeral Head Implant SystemOctober 2021April 2022Allow720YesNo
17442498ACETABULAR APPARATUSES FOR HIP REVISION SURGERYSeptember 2021June 2023Allow2100NoNo
17447575MECHANICAL ASSEMBLY INCLUDING EXTERIOR SURFACE PREPARATIONSeptember 2021February 2025Abandon4110NoNo
17472116MULTIPLE EXPANSION STAGE INTERBODY DEVICESSeptember 2021August 2024Allow3610NoNo
17403561SPINAL CAGE HAVING DEPLOYABLE MEMBERAugust 2021August 2024Allow3610NoNo
17398783IMPLANT AND ANCHOR ASSEMBLYAugust 2021September 2024Allow3810YesNo
17383839PROSTHETIC VALVE LEAFLETJuly 2021November 2025Allow5231NoNo
17379894TOTAL SHOULDER PROSTHESIS HAVING INSET GLENOID IMPLANT CONVERTIBLE FROM ANATOMIC TO REVERSEJuly 2021January 2025Allow4210YesNo
17374275FEMORAL COMPONENT FOR AN IMPLANTABLE HIP PROSTHESIS AND METHOD OF MAKING SAMEJuly 2021January 2025Allow4211NoNo
17369726LYMPH NODE REPLACEMENT CONSTRUCTJuly 2021October 2025Allow5101NoNo
17366867HINGE JOINT SYSTEM WITH DISTAL FEMORAL REPLACEMENT PROSTHETIC KNEEJuly 2021February 2024Allow3100NoNo
17364926HIP JOINT DEVICE AND METHODJuly 2021September 2025Allow5121NoNo
17364681ACTUATORS FOR ASSISTIVE WEARABLE DEVICESJune 2021June 2024Allow3600NoNo
17419446CUSTOMIZED ARTIFICIAL TEMPOROMANDIBULAR JOINT UNITJune 2021November 2023Allow2810NoNo
17357304JOINT SPACERSJune 2021February 2025Allow4420YesNo
17352051DEVICES AND METHODS FOR SPINAL IMPLANTATIONJune 2021June 2025Allow4810NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner DUKERT, BRIAN AINSLEY.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
5
Examiner Affirmed
3
(60.0%)
Examiner Reversed
2
(40.0%)
Reversal Percentile
63.4%
Higher than average

What This Means

With a 40.0% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is above the USPTO average, indicating that appeals have better success here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
8
Allowed After Appeal Filing
3
(37.5%)
Not Allowed After Appeal Filing
5
(62.5%)
Filing Benefit Percentile
62.3%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 37.5% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner DUKERT, BRIAN AINSLEY - Prosecution Strategy Guide

Executive Summary

Examiner DUKERT, BRIAN AINSLEY works in Art Unit 3774 and has examined 421 patent applications in our dataset. With an allowance rate of 89.3%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 28 months.

Allowance Patterns

Examiner DUKERT, BRIAN AINSLEY's allowance rate of 89.3% places them in the 71% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.

Office Action Patterns

On average, applications examined by DUKERT, BRIAN AINSLEY receive 1.61 office actions before reaching final disposition. This places the examiner in the 31% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by DUKERT, BRIAN AINSLEY is 28 months. This places the examiner in the 71% percentile for prosecution speed. Prosecution timelines are slightly faster than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +6.0% benefit to allowance rate for applications examined by DUKERT, BRIAN AINSLEY. This interview benefit is in the 33% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 38.9% of applications are subsequently allowed. This success rate is in the 89% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 47.7% of cases where such amendments are filed. This entry rate is in the 72% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 80.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 64% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 50.0% of appeals filed. This is in the 21% percentile among all examiners. Of these withdrawals, 40.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.

Petition Practice

When applicants file petitions regarding this examiner's actions, 54.8% are granted (fully or in part). This grant rate is in the 56% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 46% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 1.6% of allowed cases (in the 66% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • RCEs are effective: This examiner has a high allowance rate after RCE compared to others. If you receive a final rejection and have substantive amendments or arguments, an RCE is likely to be successful.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.